VA: best-corrected, 20/100 OU, deteriorating to 20/400 OU; Color vision: 9.5/10 OU
Presenting Symptom
Bilateral vision loss
Neuroimaging
MRI
Treatment
HAART therapy
Date
2008-03
References
1. Drake AK, Loy CT, Brew BJ, Chen TCC, Petoumenos K, Li PCK, Wright EJ. Human immunodeficiency virus-associated progressive multifocal leucoencephalopathy: epidemiology and predictive factors for prolonged survival. Eur J Neurol 14:418-23, 2007. 2. Wyen C, Lehmann C, Fatkenheuer G, Hoffmann C. AIDS-related progressive multifocalleukoencephalopathy in the era of HAART: report of two cases and review of literature. AIDS Patient Care andSTDs 19:486-94, 2005.
Language
eng
Format
video/mp4
Type
Image/MovingImage
Source
40th Annual Frank Walsh Society Meeting
Relation is Part of
NANOS Annual Meeting Frank B. Walsh Sessions; 2008